US Stock MarketDetailed Quotes

WINT Windtree Therapeutics

Watchlist
  • 3.1800
  • -0.2600-7.56%
Close Feb 28 16:00 ET
  • 3.1100
  • -0.0700-2.20%
Post 20:01 ET
702.70KMarket Cap0.00P/E (TTM)

About Windtree Therapeutics Company

Windtree Therapeutics, Inc. is a clinical-stage biopharmaceutical and medical device company engaged in the development of novel therapeutics intended to address significant unmet medical needs in important acute care markets. It focuses on the treatment of acute cardiovascular and acute pulmonary diseases. The company was founded by Evan Myrianthopoulos and James S. Kuo on November 6, 1992 and is headquartered in Warrington, PA.

Company Profile

SymbolWINT
Company NameWindtree Therapeutics
Listing DateAug 8, 1995
Issue Price3.50
Founded1992
CEOMr. Jed A. Latkin
MarketNASDAQ
Employees15
Fiscal Year Ends12-31
Address2600 Kelly Road,Suite 100
CityWarrington
ProvincePennsylvania
CountryUnited States of America
Zip Code18976-3622
Phone1-215-488-9300
Websitehttp://www.windtreetx.com

Company Executives

  • Name
  • Position
  • Salary
  • Jed A. Latkin
  • Director, President and Chief Executive Officer
  • --
  • Eric Curtis
  • Senior Vice President and Chief Operating Officer
  • 451.73K
  • Jamie McAndrew
  • Senior Vice President, Principal Accounting Officer and Chief Financial Officer
  • --
  • Dr. Steven G. Simonson, M.D.
  • Senior Vice President and Chief Medical Officer
  • 491.73K
  • Craig E. Fraser
  • Chairman of the Board
  • 693.63K
  • Dr. Mark Strobeck, PhD
  • Lead Independent Director
  • 32.34K
  • Leanne M. Kelly
  • Independent Director
  • --
  • Saundra Pelletier
  • Independent Director
  • --

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
LINTEX
920106
+30.00%
LINGOOD
833284
+29.98%
NTGEC
870436
+29.98%
4
CG MED EQUIP.
838810
+29.97%
5
Jiayu Holding
300117
+20.48%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio? Show More
FOMC Press Conference, January 29, 2025